Form 4: ClearPoint Neuro CFO Increases Stake Through Employee Stock Purchase Plan

ClearPoint Neuro's Chief Financial Officer, Danilo D'Alessandro, acquired 376 shares of common stock at $10.15 per share through the company's Employee Stock Purchase Plan.

Summary

• Danilo D'Alessandro, Chief Financial Officer of ClearPoint Neuro, Inc. (CLPT), acquired 376 shares of the company's common stock.
• The transaction occurred on June 30, 2025, and was reported on July 2, 2025.
• Shares were acquired at a price of $10.15 per share.
• The acquisition was made pursuant to the company's Employee Stock Purchase Plan (ESPP) for the purchase period of January 1, 2025, through June 30, 2025.
• Under the ESPP, shares were purchased at the lesser of 85% of the fair market value on either the first day or the last day of the purchase period.
• Following this transaction, Danilo D'Alessandro beneficially owns a total of 66,368 shares of ClearPoint Neuro, Inc. common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive through an Employee Stock Purchase Plan is generally viewed positively as it indicates alignment of interests with shareholders and confidence in the company's future, although it is a routine transaction rather than a discretionary open-market purchase.

Positives

• Chief Financial Officer Danilo D'Alessandro increased his direct ownership in ClearPoint Neuro, Inc. by acquiring 376 shares, signaling confidence in the company's future.
• The acquisition was made through the Employee Stock Purchase Plan (ESPP), indicating participation in a broad-based employee benefit program and alignment of interests with other employees.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, which suggests a pre-planned, non-discretionary purchase, often viewed as a more genuine indicator of long-term conviction.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• Danilo D'Alessandro, Chief Financial Officer, voluntarily reported the acquisition of common stock pursuant to the Employee Stock Purchase Plan (ESPP).
• The acquisition was made in accordance with the ESPP, where shares were purchased at the lesser of 85% of the fair market value on either the first or last day of the purchase period.

Industry Context

This Form 4 filing details an insider transaction specific to ClearPoint Neuro, Inc. and its Chief Financial Officer, Danilo D'Alessandro. It does not provide information on broader industry trends or competitive landscape.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: The acquisition by a key executive may be perceived as a positive signal of management's confidence in the company's prospects, potentially bolstering investor sentiment.
• Employees: The transaction highlights management's participation in the Employee Stock Purchase Plan, aligning executive interests with those of the broader employee base.

Next Steps

• NA

Key Dates

Keywords

ClearPoint Neuro, CLPT, Form 4, SEC filing, insider transaction, stock acquisition, employee stock purchase plan, ESPP, Danilo D'Alessandro, Chief Financial Officer